Skip to main content
. Author manuscript; available in PMC: 2022 Mar 11.
Published in final edited form as: Breast Cancer Res Treat. 2020 Sep 2;184(3):689–698. doi: 10.1007/s10549-020-05884-z

Table 1.

Patient characteristics of basal-like breast cancer cohort

Factors RNA-seq (N = 190)
N (%)
Age
 Median (min, max) 54 (29, 90)
Menopausal status Pre 38 (20%)
 Peri 10 (5%)
 Post 117 (62%)
 Indeterminate 11 (6%)
 Unknown 14 (7%)
Race White 111 (58%)
 Black 64 (34%)
 Asian 7 (4%)
 Unknown 8 (4%)
T stage
 T1 37 (19%)
 T2 127 (67%)
 T3 19 (10%)
 T4 6 (3%)
 Unknown 1 (1%)
N stage
 N0 118 (62%)
 N1 51 (27%)
 N2 15 (8%)
 N3 6 (3%)
M stage
 M0 165 (87%)
 M1 4 (2%)
 Unknown 21 (11%)
ER
 Positive 21 (11%)
 Negative 162 (85%)
 Unknown 7 (4%)
PR
 Positive 12 (6%)
 Negative 169 (89%)
 Unknown 9 (5%)
HER2
 Positive 6 (3%)
 Negative 180 (95%)
 Unknown 4 (2%)
DFI
 Event 22 (12%)
 Event-free 148 (78%)
 Unknown 20 (10%)
PFI
 Event 29 (15%)
 Event-free 161 (85%)